Latest News about biotech
Recent news which mentions biotech
Why Is Regeneron Pharmaceuticals Stock Trading Lower Today?
October 31, 2024
From Benzinga
Bristol Myers Squibb Boosts 2024 Outlook On Strong Demand For Blood Thinner Med, New Drugs Drive Q3 Profit
October 31, 2024
From Benzinga
Incyte's Jakafi Demand Is Strong, Analyst Upgrades Stock
October 30, 2024
From Benzinga
Positive Outlook For Novartis As Company Capitalizes On Growing Treatment Opportunities, Analyst Highlights
October 30, 2024
From Benzinga
From Benzinga
From Benzinga
Biogen's Q3 Profit Beats Expectations On Lower Multiple Sclerosis Revenues But New Products Offset Losses, Raises Profit Outlook
October 30, 2024
From Benzinga
AbbVie Tops Q3 Expectations As Skyrizi, Rinvoq Drive Growth
October 30, 2024
From Benzinga
GSK's Q3 Earnings Hit By Lower Than Expected Vaccine Sales, Cautions Lower Revenue For 2024
October 30, 2024
From Benzinga
Eli Lilly Q3 Earnings: Mounjaro Sales More Than Double, Takes $2.98 Billion Hit To Profit, Cuts Annual Outlook, Stock Tanks
October 30, 2024
From Benzinga
Coya Therapeutics' High-Dose Interleukin-2 Misses The Mark In Mid-Stage Alzheimer's Study
October 29, 2024
From Benzinga
From Benzinga
AbbVie Chart Reflects Bearish Signals Ahead Of Q3 Earnings
October 29, 2024
From Benzinga
Incyte Clocks Mixed Q3 Earnings, But Analyst Sees A Strong Quarter For Jakafi And Opzelura
October 29, 2024
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.